Sort
50,496 grants matching “lung cancer”
Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity
$729,587Olivier Morin · University Of California, San Francisco · R01 · FY2025 · CA
Product Testing Animal Core
$729,492Keisuke S. Iwamoto · University Of California Los Angeles · U19 · FY2015 · AI
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
$729,484Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
$729,483Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer
$729,441Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations
$729,340Debra P Ritzwoller · Kaiser Foundation Research Institute · UM1 · FY2023 · CA
Technology Innovations for Supporting Health in Alaska Native People
$729,321Judith J. Prochaska · Stanford University · R01 · FY2016 · HL
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$729,283Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA
FATIGUE, PAIN, AND SLEEP PROBLEMS DURING RADIATION
$729,177University Of California San Francisco · R01 · FY2000 · NR
Genetic Epidemiology of Lung Cancer
$729,169Ann G Schwartz · Wayne State University · R01 · FY2008 · CA
Impact of Cellular and Extracellular Host Components on Tumor Progression
$729,039Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2015 · CA
Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer
$728,990Ryan Bruce Corcoran · Massachusetts General Hospital · R01 · FY2022 · CA
A High Performance Digital Medical Data Link Technology
$728,989Physical Optics Corporation · R44 · FY2004 · LM
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.
$728,983Katerina Abigail Politi · Yale University · U01 · FY2023 · CA
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
$728,904Bastiaan Driehuys · Duke University · R01 · FY2021 · HL
Oxidative stress, Cr(VI) carcinogenesis, and prevention
$728,875Xianglin Shi · University Of Kentucky · R01 · FY2019 · ES
Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing
$728,864Yutaka Yasui · St. Jude Children'S Research Hospital · R01 · FY2019 · CA
A genomewide study of lung cancer in never smokers
$728,823Olga Gorlova · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Dysregulation of sphingolipid metabolism and signaling in LAM
$728,776Jane Yu · University Of Cincinnati · R01 · FY2025 · HL
Advancing Geriatrics Infrastructure & Network Growth
$728,696Jerry H Gurwitz · Univ Of Massachusetts Med Sch Worcester · R24 · FY2014 · AG
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study
$728,630Laurence Huang · University Of California, San Francisco · R01 · FY2017 · HL
The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers
$728,442George R Washko · Brigham And Women'S Hospital · R01 · FY2018 · HL
Ms. LILAC: Muscle Mass in the Life and Longevity After Cancer (LILAC) Study
$728,401Hailey Rose Banack · State University Of New York At Buffalo · R37 · FY2022 · CA
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
$728,283R Graham Barr · Columbia University Health Sciences · R01 · FY2022 · HL
Mechanisms in Perinatal Carcinogenesis
$728,236Lucy M Anderson · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA